USD 84.74
(-0.94%)
Year | Net Debt | Net Debt Growth |
---|---|---|
2023 | 4.04 Billion USD | -0.94% |
2022 | 4.08 Billion USD | 40.77% |
2021 | 2.9 Billion USD | -1.19% |
2020 | 2.93 Billion USD | -1.44% |
2019 | 2.98 Billion USD | 3376.92% |
2018 | -91 Million USD | -295.65% |
2017 | -23 Million USD | -126.44% |
2016 | 87 Million USD | 4250.0% |
2015 | 2 Million USD | 0.0% |
Year | Net Debt | Net Debt Growth |
---|---|---|
2024 Q2 | 3.71 Billion USD | -5.78% |
2024 Q1 | 3.94 Billion USD | -2.58% |
2023 Q2 | 4.44 Billion USD | 5.23% |
2023 Q1 | 4.22 Billion USD | 3.25% |
2023 Q3 | 4.05 Billion USD | -8.69% |
2023 FY | 4.04 Billion USD | -0.94% |
2023 Q4 | 4.04 Billion USD | -0.15% |
2022 FY | 4.08 Billion USD | 40.77% |
2022 Q4 | 4.08 Billion USD | 29.53% |
2022 Q2 | 3.34 Billion USD | -3.96% |
2022 Q1 | 3.48 Billion USD | 20.08% |
2022 Q3 | 3.15 Billion USD | -5.76% |
2021 FY | 2.9 Billion USD | -1.19% |
2021 Q4 | 2.9 Billion USD | -0.89% |
2021 Q1 | 2.94 Billion USD | 0.14% |
2021 Q2 | 3.13 Billion USD | 6.63% |
2021 Q3 | 2.93 Billion USD | -6.63% |
2020 Q2 | 3.18 Billion USD | 5.05% |
2020 FY | 2.93 Billion USD | -1.44% |
2020 Q4 | 2.93 Billion USD | -3.89% |
2020 Q3 | 3.05 Billion USD | -3.84% |
2020 Q1 | 3.02 Billion USD | 1.51% |
2019 Q1 | 258 Million USD | 383.52% |
2019 FY | 2.98 Billion USD | 3376.92% |
2019 Q4 | 2.98 Billion USD | 1.95% |
2019 Q3 | 2.92 Billion USD | -3.18% |
2019 Q2 | 3.02 Billion USD | 1070.93% |
2018 Q3 | 63 Million USD | 0.0% |
2018 FY | -91 Million USD | -295.65% |
2018 Q1 | 172 Million USD | 647.83% |
2018 Q4 | -91 Million USD | -244.44% |
2017 Q4 | 23 Million USD | 0.0% |
2017 FY | -23 Million USD | -126.44% |
2016 FY | 87 Million USD | 4250.0% |
2015 FY | 2 Million USD | 0.0% |
Name | Net Debt | Net Debt Difference |
---|---|---|
AptarGroup, Inc. | 961.03 Million USD | -321.383% |
Baxter International Inc. | 11.16 Billion USD | 63.733% |
Becton, Dickinson and Company | 14.46 Billion USD | 72.0% |
Bausch + Lomb Corporation | 4.23 Billion USD | 4.287% |
Haemonetics Corporation | 695.08 Million USD | -482.61% |
Envista Holdings Corp | 713.6 Million USD | -467.493% |
ResMed Inc. | 635.57 Million USD | -537.161% |
Teleflex Incorporated | 1.7 Billion USD | -137.721% |
Warby Parker Inc. | -42.43 Million USD | 9642.683% |
West Pharmaceutical Services, Inc. | -544.9 Million USD | 843.187% |